Humana Stock Rises 14% Following Improved Medicare Ratings
Humana's stock surged approximately 14% in premarket trading following the release of new Medicare Advantage quality ratings that showed a significant improvement for the insurer. In contrast, rival CVS Health faced weaker results for its Aetna business. The rally was driven by confirmation that 95% of Humana's Medicare Advantage members are enrolled in plans rated four stars or higher for 2027, a notable increase from about 20% under the previous year's ratings.
According to the official ratings from the Centers for Medicare & Medicaid Services (CMS), these changes will impact insurers' quality bonus payments in 2028. This turnaround could represent a substantial financial benefit for Humana, with analysts estimating an additional revenue potential of approximately $3.6 billion. Humana's largest Medicare Advantage contract, H5216, improved from 3.5 to four stars, which could restore its eligibility for government quality bonuses. This contract covers approximately 2.4 million members, making the improvement particularly significant.
For Your Trading Desk
Sponsor Spike Success.
Additionally, Humana announced that 42% of its Medicare Advantage members are now enrolled in plans rated at least 4.5 stars. This improvement comes after years of financial pressure related to ratings that previously weakened profitability and forced insurers to reconsider their coverage strategies. Recent changes in the Medicare Advantage landscape have prompted Humana, CVS, and UnitedHealth to adjust their geographic footprints or plan availability.
In contrast, CVS Health's Aetna reported that more than 69% of its Medicare Advantage members will be enrolled in four-star or higher plans in 2027, down from over 81% for 2026. Although Aetna emphasized its clinical performance in an official statement, this decline raises concerns about future quality bonuses. Following the ratings results, CVS shares slipped approximately 2%, while UnitedHealth also faced pressure.
Impact of Medicare Payment Changes on Industry Performance
The divergence in performance is notable, especially as the industry recently benefited from a Medicare payment increase that initially lifted major health insurance stocks.
Market Reactions and Future Implications
The market's reaction to these ratings highlights the competitive landscape among health insurers. Humana's significant gains reflect investor confidence in its improved ratings and potential for increased revenue. Conversely, CVS Health's decline signals challenges ahead as it navigates the implications of its lower ratings. As the Medicare Advantage market continues to evolve, the performance of these companies will be closely monitored by investors and analysts alike.
Ethan Mercer is a financial journalist covering crypto, stocks, and the global economy. He studied Economics and Finance and later moved into market reporting, with a particular interest in Bitcoin, equities, monetary policy, and investor sentiment. His work focuses on explaining daily market moves and the broader trends behind them.




